These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 30602726)

  • 21. Cancer: an epigenetic landscape.
    Dhanasekaran K; Arif M; Kundu TK
    Subcell Biochem; 2013; 61():399-417. PubMed ID: 23150260
    [No Abstract]   [Full Text] [Related]  

  • 22. Histone profiles in cancer.
    Riedel SS; Neff T; Bernt KM
    Pharmacol Ther; 2015 Oct; 154():87-109. PubMed ID: 26210403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Greater Than the Sum of Parts: Complexity of the Dynamic Epigenome.
    Soshnev AA; Josefowicz SZ; Allis CD
    Mol Cell; 2016 Jun; 62(5):681-94. PubMed ID: 27259201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chromatin response to DNA breaks: leaving a mark on genome integrity.
    Smeenk G; van Attikum H
    Annu Rev Biochem; 2013; 82():55-80. PubMed ID: 23414304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presenting the epigenome roadmap.
    Skipper M; Eccleston A; Gray N; Heemels T; Le Bot N; Marte B; Weiss U
    Nature; 2015 Feb; 518(7539):313. PubMed ID: 25693561
    [No Abstract]   [Full Text] [Related]  

  • 26. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of the 3D cancer genome blueprint.
    Achinger-Kawecka J; Clark SJ
    Epigenomics; 2017 Jan; 9(1):47-55. PubMed ID: 27936932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The self-stirred genome: large-scale chromatin dynamics, its biophysical origins and implications.
    Zidovska A
    Curr Opin Genet Dev; 2020 Apr; 61():83-90. PubMed ID: 32497955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
    Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
    BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA modifies chromatin: epigenetic silencing by long non-coding RNAs.
    Saxena A; Carninci P
    Bioessays; 2011 Nov; 33(11):830-9. PubMed ID: 21915889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
    Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
    Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Driver mutations of cancer epigenomes.
    Roy DM; Walsh LA; Chan TA
    Protein Cell; 2014 Apr; 5(4):265-96. PubMed ID: 24622842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer.
    Hon GC; Hawkins RD; Caballero OL; Lo C; Lister R; Pelizzola M; Valsesia A; Ye Z; Kuan S; Edsall LE; Camargo AA; Stevenson BJ; Ecker JR; Bafna V; Strausberg RL; Simpson AJ; Ren B
    Genome Res; 2012 Feb; 22(2):246-58. PubMed ID: 22156296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromatin modifiers and remodellers: regulators of cellular differentiation.
    Chen T; Dent SY
    Nat Rev Genet; 2014 Feb; 15(2):93-106. PubMed ID: 24366184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.
    Zhou S; Treloar AE; Lupien M
    Cancer Discov; 2016 Nov; 6(11):1215-1229. PubMed ID: 27807102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in Three-Dimensional Organization of the Cancer Genome and Epigenome.
    Achinger-Kawecka J; Taberlay PC; Clark SJ
    Cold Spring Harb Symp Quant Biol; 2016; 81():41-51. PubMed ID: 28424341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic regulation of cancer stem cell gene expression.
    Bapat SA
    Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concise review: chromatin and genome organization in reprogramming.
    Biran A; Meshorer E
    Stem Cells; 2012 Sep; 30(9):1793-9. PubMed ID: 22782851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-Wide Profiling of PARP1 Reveals an Interplay with Gene Regulatory Regions and DNA Methylation.
    Nalabothula N; Al-jumaily T; Eteleeb AM; Flight RM; Xiaorong S; Moseley H; Rouchka EC; Fondufe-Mittendorf YN
    PLoS One; 2015; 10(8):e0135410. PubMed ID: 26305327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating the structural features of chromodomain proteins in the human genome and predictive impacts of their mutations in cancers.
    Dahiya R; Naqvi AAT; Mohammad T; Alajmi MF; Rehman MT; Hussain A; Hassan MI
    Int J Biol Macromol; 2019 Jun; 131():1101-1116. PubMed ID: 30917913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.